Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Pharmacol Biochem Behav. 2012 Nov;103(1):6–17. doi: 10.1016/j.pbb.2012.07.006

Figure 6.

Figure 6

Striatal dopamine receptor expression in bHR and bLR rats exposed to neonatal FGF2. At baseline, bLRs showed reduced D1 receptor mRNA in the nucleus accumbens core (AcbC; A) and shell (AcbSh; C), as well as increased D2 receptor mRNA in the AcbC (B) and caudate putamen (CPu; F) compared to bHRs. Neonatal FGF2 treatment differentially affected gene expression in bLR versus bHRs, leading to selectively increased D1 levels in the AcbC of bLRs (A), but decreased D1 in the AcbSh (C) and CPu (E) of bHRs. n=8 per experimental group; *** indicates p<0.0001; * indicates p<0.05